Is Your Elderberry Supplement Adulterated? What the New BAPP Lab Guide Means for Buyers in India (2026)

Approximately 17.1% of elderberry supplement samples examined in a peer-reviewed 2024 systematic review were found to be adulterated or mislabeled — and a landmark new laboratory guidance document published in September 2026 by the Botanical Adulterants Prevention Program (BAPP) now gives responsible companies, quality-control labs, and informed consumers the clearest toolkit yet to detect that fraud. For Indian buyers navigating an import-heavy supplement market with limited domestic regulatory oversight of botanical ingredients, the implications are direct and practical.

European elderberry (Sambucus nigra) is a flowering plant in the family Viburnaceae whose dark purple-black berries are standardised for anthocyanin content and used globally as an immune-support supplement. The new BAPP Lab Guidance Document, released on 16 September 2026, reviews and assesses the fitness and reliability of 22 laboratory analytical methods to confirm the identity of authentic elderberry — the most comprehensive single-document resource ever published on the topic.

Before diving into what the guide means for you, here is a snapshot comparison of the five botanicals BAPP studied for adulteration rates, alongside elderberry's specific fraud profile:

Botanical	Samples Reviewed	Adulteration Rate	Primary Fraud Method
Ginkgo leaf	533	56.7%	Synthetic flavonoid spiking
Black cohosh rhizome	322	42.2%	Substitution with related Actaea spp.
Echinacea root/herb	200	28.5%	Species substitution, underdosing
Elderberry	695	17.1%	Black rice extract, food dyes
Turmeric root/rhizome	1,247	16.5%	Synthetic curcumin, starch fillers

Source: BAPP systematic review, Nutritional Outlook, September 2024

Elderberry's 17.1% adulteration rate places it mid-table among the most popular botanicals — but that figure almost certainly understates real-world risk during peak demand periods. During the COVID-19 pandemic, when supply chains were overwhelmed and hundreds of new products launched almost overnight, the opportunity for fraud was far greater. The market has since contracted, but fraudsters refined their techniques during those years, and those techniques persist.

What exactly is the BAPP Lab Guidance Document, and why does it matter?

The Botanical Adulterants Prevention Program (BAPP) is an international consortium of nonprofit organisations — primarily the American Botanical Council (ABC), the American Herbal Pharmacopoeia (AHP), and the National Center for Natural Products Research (NCNPR) at the University of Mississippi — that produces peer-reviewed, freely available educational resources to help the herbal and dietary supplement industry detect and prevent ingredient fraud.

The new elderberry Lab Guidance Document (LGD) was published on 16 September 2026 and authored by three specialists: Oleksandr Shulha, Ph.D. (natural products chemistry and analysis, Ukraine), Gökalp İşcan, Ph.D. (botanical microscopy, Anadolu University, Turkey), and Golshan Zare, Ph.D. (botanist, Hacettepe University, Turkey). Seventeen additional subject-matter experts peer-reviewed it before publication.

What makes this document significant is its scope. Rather than simply documenting that adulteration exists — BAPP did that in a 2023 bulletin — the new LGD goes further by reviewing 22 analytical methods and telling laboratories which ones are actually fit for purpose and which ones fraudsters have already learned to game. That distinction is critical.

As BAPP founder Mark Blumenthal explained: "We show them which analytical methods are no longer fit for purpose because the fraudsters are gaming the system. If a company doesn't use the proper method, or the proper combination of multiple solid methods, they can authenticate material that is in fact adulterated." This is not a theoretical concern — adulterators have for years tailored their substitutes to produce the expected chemical signatures on simpler tests, such as adding anthocyanin-rich black rice extract that mimics elderberry's characteristic purple pigment profile on basic colorimetric assays.

The LGD covers four broad categories of analytical methods:

Chromatographic methods — such as HPLC and UHPLC, which separate and identify individual anthocyanin compounds. Genuine elderberry has a specific cyanidin-based anthocyanin fingerprint that differs from black rice.
Spectrometric and spectroscopic methods — including mass spectrometry and NMR, which determine molecular structure and can catch sophisticated substitutions.
DNA-based genetic methods, which identify the plant species at the genomic level, bypassing any chemical camouflage.
Macroscopic and microscopic examination, visual and microscope-based inspection of raw plant material, with original research included on the usefulness and limitations of these approaches.

Stefan Gafner, Ph.D., chief science officer of ABC and director of BAPP, stated: "Any company purchasing elderberry extracts must use fit-for-purpose laboratory methods to determine ingredient authenticity and detect possible adulteration. The new [guidance] has the most up-to-date information for the selection of reliable analytical methods conveniently summarised in one document."

All BAPP publications, including this LGD, are freely available on the program's website upon registration — a deliberate policy to lower the barrier for smaller companies and independent labs.

Why is elderberry adulteration so economically attractive to fraudsters?

The financial logic of elderberry fraud is straightforward and documented. Genuine elderberry extract costs up to 30 times more than black rice (Oryza sativa) extract — the most common adulterant, as summarised in BAPP's 2023 elderberry adulteration bulletin. Both are anthocyanin-rich and visually similar. A fraudulent supplier who substitutes even a fraction of the elderberry content with black rice extract can dramatically improve margins while passing basic quality checks.

The elderberry market's pandemic-era trajectory made this worse. The annual Herb Market Report compiled by the American Botanical Council found that US elderberry product sales reached $329.6 million in 2020 and $304.9 million in 2021 across mainstream and natural channels combined. That explosive demand far outpaced the supply chain's capacity to deliver authentic ingredient. By 2025, the combined market had contracted to approximately $136 million — still a substantial figure, and still enough to sustain fraudulent activity.

The common adulterants seen in elderberry products, as documented across multiple peer-reviewed sources, include:

Black rice (Oryza sativa) extracts — the most frequently detected adulterant, rich in cyanidin-3-glucoside, which overlaps with elderberry's anthocyanin profile on simple tests.
Other anthocyanin-rich plant extracts — from sources such as grape skin, bilberry, or aronia, which can substitute for elderberry's visual and basic chemical characteristics.
Blue or purple synthetic food colorants, the crudest form of adulteration, but still encountered, particularly in lower-cost products.

The 2023 BAPP bulletin — BAPP's 27th publication at the time — was the first peer-reviewed document to confirm the adulteration of elderberry ingredients sold in the international market. The 2026 LGD builds on that foundation by telling the industry precisely how to catch these substitutions.

What does the science say about genuine elderberry's health benefits?

This question matters because adulteration is not merely a regulatory technicality — it means consumers are paying for a product they are not receiving, and missing out on documented clinical benefits.

Genuine European elderberry (Sambucus nigra) is a botanical whose immunomodulatory effects are attributed primarily to its anthocyanin content — particularly cyanidin-3-sambubioside and cyanidin-3-glucoside — along with flavonoids and other polyphenols. Several clinical studies support its use for upper respiratory infections.

A landmark randomised, double-blind, placebo-controlled trial involving 283 healthy Australian adults travelling on long-haul flights found that elderberry supplementation significantly reduced cold duration and symptom severity. The placebo group's collective cold symptom duration was 117 days versus 57 days in the elderberry group — a statistically significant difference (p = 0.05). The elderberry group's collective symptom score was also substantially lower (247 vs. 583, p = 0.02).

A 2019 meta-analysis of four clinical trials involving 180 subjects found that elderberry supplementation reduced both the severity and duration of upper respiratory symptoms in cold and flu patients. These findings are the basis for elderberry's continued commercial relevance even as the pandemic-era surge has faded.

The critical point for buyers: none of these benefits transfer to a product adulterated with black rice extract or food dye. Black rice anthocyanins have their own health properties, but they are not interchangeable with elderberry's specific phytochemical profile, and they have not been studied in the same clinical context.

How does this affect Indian supplement buyers specifically?

India's supplement market is growing rapidly, and elderberry products — primarily imported as finished capsules, gummies, syrups, and powders — have found a niche among urban consumers focused on immune health. The regulatory environment for imported botanical supplements in India is governed by the Food Safety and Standards Authority of India (FSSAI), but enforcement of ingredient authenticity at the molecular level is not routine.

This creates a structural vulnerability. An Indian consumer purchasing an elderberry supplement — whether from a domestic e-commerce platform, a pharmacy chain, or a health food store — has essentially no independent mechanism to verify that the product contains what the label claims. The brand's own quality control is the primary safeguard, and that quality control is only as good as the analytical methods the company uses.

The BAPP LGD is directly relevant here because it tells purchasing managers and quality-control teams at Indian supplement companies — and their international suppliers — which tests to demand. A supplier who can only provide a basic colorimetric anthocyanin assay result is not providing adequate authentication. A supplier who can provide HPLC anthocyanin fingerprinting, ideally combined with DNA-based species confirmation, is offering a meaningfully higher standard of assurance.

For individual consumers, the practical implication is to look for brands that:

Source from suppliers with documented third-party testing using chromatographic or DNA-based methods.
Carry certifications from recognised quality bodies (NSF International, USP, or equivalent).
Can provide a Certificate of Analysis (CoA) that specifies the analytical method used, not merely the result.
Are transparent about their elderberry extract's origin and standardisation (typically expressed as a percentage of anthocyanins by HPLC).

The BAPP programme is funded entirely by donations and makes all its materials freely available — meaning any Indian company importing elderberry ingredients can access the same guidance documents that major US supplement brands use, at no cost.

How has BAPP's broader programme evolved, and what does its track record tell us?

BAPP reached a significant milestone in 2026: more than 15 years of operation and over 100 peer-reviewed publications, including 17 lab guidance documents covering a range of botanicals. The elderberry LGD is the latest in that series, following a June 2026 LGD on echinacea and a February 2026 full review on turmeric adulteration.

The programme's 2024 systematic review, published in Natural Product Reports, examined 78 publications covering 2,995 samples across five botanicals. Of those samples, 818 — roughly 27% overall — were reported to be adulterated or mislabeled. The authors, including Gafner and ABC founder Mark Blumenthal, were careful to note that "the numbers obtained for the extent of adulteration of the five botanicals investigated for this systematic review may not be representative for the overall adulteration rate in the global herbal dietary and food supplement industry, but it is clear that adulteration of botanical ingredients is a problem and impacts a substantial portion of products sold as dietary or food supplement."

That caveat matters. The 17.1% figure for elderberry is derived from published studies, which tend to focus on products where adulteration is already suspected. The true market-wide rate could be lower — or higher. The data is also not static: BAPP noted in 2023 that some brands which entered the market at the height of pandemic demand, and which may have unknowingly sold adulterated products, appear to have since exited, improving the overall quality of available elderberry supplements.

What BAPP's track record demonstrates is that adulteration is not a static problem. Fraudsters adapt. When HPLC became standard, adulterators began sourcing black rice extract with anthocyanin profiles calibrated to pass HPLC screening. The response — documented in the new LGD — is to use multiple orthogonal methods simultaneously, so that a sample must pass chromatographic, spectrometric, and genetic tests before it can be authenticated. No single method is sufficient.

What should Indian brands and importers do right now?

The BAPP LGD is a technical document aimed at laboratories and quality-control professionals, but its practical implications for procurement and brand management are clear.

For brands importing elderberry ingredients: Request a full analytical package from your supplier that includes HPLC anthocyanin fingerprinting (not just total anthocyanin content by pH differential method), and ideally DNA-based species identification. The pH differential method — which measures total anthocyanin content colorimetrically — is specifically flagged in BAPP literature as insufficient on its own, because black rice extract can produce similar total anthocyanin readings to genuine elderberry.

For contract manufacturers: If you are formulating elderberry products for Indian brands, your incoming ingredient testing protocol should be updated to reflect the methods assessed in the 2026 LGD. The document is freely available through BAPP's website (registration required at herbalgram.org).

For retailers and e-commerce platforms: Supplier qualification processes should require documentation of analytical method type, not just a pass/fail result. A CoA that says "anthocyanins: 13% — PASS" without specifying the method used is not meaningful authentication.

For consumers: The supplement market in India, as in most countries, places the burden of quality assurance on the buyer. Choosing brands that publish their testing methodology — not just their certifications — is the most reliable proxy for ingredient authenticity available to a non-specialist. Elderberry products that are unusually cheap relative to the category average warrant particular scepticism, given the documented 30x cost differential between genuine elderberry extract and its most common adulterant.

Is the elderberry adulteration problem getting better or worse?

The honest answer is: the data is mixed, and the picture is incomplete. The positive signals are real. BAPP's 2023 bulletin noted that some responsible industry members reported market stabilisation, with brands that may have unknowingly sold adulterated products during the pandemic surge appearing to have exited the market. The overall elderberry market contraction — from $329.6 million at peak to $136 million by 2025 — has reduced the financial incentive for large-scale fraud, though it has not eliminated it.

The concerning signals are equally real. Adulterators refined their methods during the pandemic years, and those methods are now more sophisticated than they were in 2019. The fact that BAPP felt it necessary to publish a full Lab Guidance Document — going beyond the 2023 bulletin to assess 22 specific analytical methods — reflects the programme's assessment that the detection challenge has grown more complex, not simpler.

Gafner summarised the situation: "Despite a slow decline in retail sales since reaching record numbers during the height of the Covid-19 pandemic, elderberry products are still among the most widely used herbal dietary supplements in the U.S. market. The popularity of the ingredient combined with the competitiveness of the U.S. herbal dietary supplement market may prompt some unethical suppliers to sell fraudulent elderberry extracts adulterated with undisclosed lower-cost blue-colored materials."

The same dynamic applies to the Indian market, where competitive pricing pressure on imported supplements is intense and the analytical infrastructure to catch sophisticated adulteration is less developed than in the US or EU. The BAPP LGD does not solve that structural problem, but it provides the technical roadmap for any company or laboratory willing to invest in proper testing.

The bottom line for buyers in India

Elderberry adulteration is a documented, economically motivated, and technically sophisticated problem. The new BAPP Lab Guidance Document — peer-reviewed by 20 experts across three continents and assessing 22 analytical methods — is the most rigorous tool yet published to help the industry detect it. For Indian consumers and brands, the document's existence is both a warning and a resource.

The warning: a significant minority of elderberry products on the global market do not contain what their labels claim. The financial incentive for fraud is large (up to 30x cost differential), the detection barrier is real (simple tests can be fooled), and the Indian regulatory environment does not currently provide routine molecular-level authentication of imported botanical ingredients.

The resource: the BAPP LGD is freely available, written by credentialed experts, and peer-reviewed. Any Indian supplement company importing elderberry ingredients can use it to upgrade their supplier qualification and incoming testing protocols today. The elderberry supplement you buy — or sell — is only as trustworthy as the analytical methods used to verify it.

For related reading on supplement quality and evidence-based botanical ingredients in the Indian market, see our guides on berberine for insulin resistance and Arjuna for heart health — two categories where ingredient authenticity is equally critical to clinical outcomes.